サマリー

酒さ治療の世界市場 2024-2028
酒さ治療市場は2023-2028年に7億4429万米ドルで成長し、予測期間中のCAGRは6.2%で加速すると予測される。当レポートでは、酒さ治療市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、個別化された治療アプローチへの注目の高まり、より良い診断につながる酒さへの認識の高まり、市場ベンダーによる戦略の増加などが牽引しています。
Technavioの酒さ治療市場は以下のように区分される：
流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局
投与経路別
- 局所
- 経口
- 注射剤
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、今後数年間の酒さ治療市場の成長を促進する主な理由の1つとして、美容整形に対する需要の高まりを挙げている。また、併用療法への注目の高まりや、自然で優しい治療への需要の高まりは、市場の大きな需要につながる。
酒さ治療市場に関するレポートは以下の分野をカバーしています：
- 酒さ治療市場のサイジング
- 酒さ治療市場予測
- 酒さ治療市場産業分析
本レポートでは、酒さ治療市場の主要ベンダー（AbbVie Inc.、Aclaris Therapeutics Inc.、AKUMS、Bausch Health Companies Inc.、Croda International Plc、Dermata Therapeutics Inc.、Galderma SA、Glenmark Pharmaceuticals Ltd.、Hovione、Journey Medical Corp.、LEO Pharma AS、Lupin Ltd.、Maruho Co.Ltd.、Mayne Pharma Group Ltd.、Pfizer Inc.、PruGen LLC、Sol-Gel Technologies Ltd.、Taro Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Zydus Lifesciences Ltd.などである。また、酒さ治療市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/rosacea-treatment-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global rosacea treatment market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global rosacea treatment market 2018 - 2022 ($ million)
o 4.2 Distribution Channel Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
o 4.3 Route of Administration Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 30: Chart on Distribution Channel - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Distribution Channel - Market share 2023-2028 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 32: Chart on Comparison by Distribution Channel
o Exhibit 33: Data Table on Comparison by Distribution Channel
o 6.3 Hospital pharmacies - Market size and forecast 2023-2028
o Exhibit 34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
o 6.4 Retail pharmacies - Market size and forecast 2023-2028
o Exhibit 38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
o 6.5 Online pharmacies - Market size and forecast 2023-2028
o Exhibit 42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 46: Market opportunity by Distribution Channel ($ million)
o Exhibit 47: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Market Segmentation by Route of Administration
o 7.1 Market segments
o Exhibit 48: Chart on Route of Administration - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Route of Administration - Market share 2023-2028 (%)
o 7.2 Comparison by Route of Administration
o Exhibit 50: Chart on Comparison by Route of Administration
o Exhibit 51: Data Table on Comparison by Route of Administration
o 7.3 Topical - Market size and forecast 2023-2028
o Exhibit 52: Chart on Topical - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Topical - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Topical - Year-over-year growth 2023-2028 (%)
o 7.4 Oral - Market size and forecast 2023-2028
o Exhibit 56: Chart on Oral - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 7.5 Injectable - Market size and forecast 2023-2028
o Exhibit 60: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Injectable - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Route of Administration
o Exhibit 64: Market opportunity by Route of Administration ($ million)
o Exhibit 65: Data Table on Market opportunity by Route of Administration ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 Russia - Market size and forecast 2023-2028
o Exhibit 103: Chart on Russia - Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on Russia - Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on Russia - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Russia - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Aclaris Therapeutics Inc.
o Exhibit 115: Aclaris Therapeutics Inc. - Overview
o Exhibit 116: Aclaris Therapeutics Inc. - Business segments
o Exhibit 117: Aclaris Therapeutics Inc. - Key news
o Exhibit 118: Aclaris Therapeutics Inc. - Key offerings
o Exhibit 119: Aclaris Therapeutics Inc. - Segment focus
o 12.4 Bausch Health Companies Inc.
o Exhibit 120: Bausch Health Companies Inc. - Overview
o Exhibit 121: Bausch Health Companies Inc. - Business segments
o Exhibit 122: Bausch Health Companies Inc. - Key news
o Exhibit 123: Bausch Health Companies Inc. - Key offerings
o Exhibit 124: Bausch Health Companies Inc. - Segment focus
o 12.5 Croda International Plc
o Exhibit 125: Croda International Plc - Overview
o Exhibit 126: Croda International Plc - Business segments
o Exhibit 127: Croda International Plc - Key news
o Exhibit 128: Croda International Plc - Key offerings
o Exhibit 129: Croda International Plc - Segment focus
o 12.6 Galderma SA
o Exhibit 130: Galderma SA - Overview
o Exhibit 131: Galderma SA - Product / Service
o Exhibit 132: Galderma SA - Key news
o Exhibit 133: Galderma SA - Key offerings
o 12.7 Glenmark Pharmaceuticals Ltd.
o Exhibit 134: Glenmark Pharmaceuticals Ltd. - Overview
o Exhibit 135: Glenmark Pharmaceuticals Ltd. - Product / Service
o Exhibit 136: Glenmark Pharmaceuticals Ltd. - Key offerings
o 12.8 Journey Medical Corp.
o Exhibit 137: Journey Medical Corp. - Overview
o Exhibit 138: Journey Medical Corp. - Product / Service
o Exhibit 139: Journey Medical Corp. - Key offerings
o 12.9 LEO Pharma AS
o Exhibit 140: LEO Pharma AS - Overview
o Exhibit 141: LEO Pharma AS - Business segments
o Exhibit 142: LEO Pharma AS - Key offerings
o Exhibit 143: LEO Pharma AS - Segment focus
o 12.10 Lupin Ltd.
o Exhibit 144: Lupin Ltd. - Overview
o Exhibit 145: Lupin Ltd. - Product / Service
o Exhibit 146: Lupin Ltd. - Key news
o Exhibit 147: Lupin Ltd. - Key offerings
o 12.11 Maruho Co. Ltd.
o Exhibit 148: Maruho Co. Ltd. - Overview
o Exhibit 149: Maruho Co. Ltd. - Product / Service
o Exhibit 150: Maruho Co. Ltd. - Key offerings
o 12.12 Mayne Pharma Group Ltd.
o Exhibit 151: Mayne Pharma Group Ltd. - Overview
o Exhibit 152: Mayne Pharma Group Ltd. - Business segments
o Exhibit 153: Mayne Pharma Group Ltd. - Key news
o Exhibit 154: Mayne Pharma Group Ltd. - Key offerings
o Exhibit 155: Mayne Pharma Group Ltd. - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 156: Pfizer Inc. - Overview
o Exhibit 157: Pfizer Inc. - Product / Service
o Exhibit 158: Pfizer Inc. - Key news
o Exhibit 159: Pfizer Inc. - Key offerings
o 12.14 Sol-Gel Technologies Ltd.
o Exhibit 160: Sol-Gel Technologies Ltd. - Overview
o Exhibit 161: Sol-Gel Technologies Ltd. - Product / Service
o Exhibit 162: Sol-Gel Technologies Ltd. - Key offerings
o 12.15 Taro Pharmaceutical Industries Ltd.
o Exhibit 163: Taro Pharmaceutical Industries Ltd. - Overview
o Exhibit 164: Taro Pharmaceutical Industries Ltd. - Product / Service
o Exhibit 165: Taro Pharmaceutical Industries Ltd. - Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 166: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 167: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 168: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 169: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 170: Teva Pharmaceutical Industries Ltd. - Segment focus
o 12.17 Zydus Lifesciences Ltd.
o Exhibit 171: Zydus Lifesciences Ltd. - Overview
o Exhibit 172: Zydus Lifesciences Ltd. - Business segments
o Exhibit 173: Zydus Lifesciences Ltd. - Key offerings
o Exhibit 174: Zydus Lifesciences Ltd. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 175: Inclusions checklist
o Exhibit 176: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 177: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 178: Research methodology
o Exhibit 179: Validation techniques employed for market sizing
o Exhibit 180: Information sources
o 13.5 List of abbreviations
o Exhibit 181: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global rosacea treatment market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits31: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Distribution Channel
Exhibits33: Data Table on Comparison by Distribution Channel
Exhibits34: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Distribution Channel ($ million)
Exhibits47: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits48: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits49: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Route of Administration
Exhibits51: Data Table on Comparison by Route of Administration
Exhibits52: Chart on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Topical - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Topical - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Route of Administration ($ million)
Exhibits65: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Russia - Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on Russia - Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on Russia - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Russia - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Aclaris Therapeutics Inc. - Overview
Exhibits116: Aclaris Therapeutics Inc. - Business segments
Exhibits117: Aclaris Therapeutics Inc. - Key news
Exhibits118: Aclaris Therapeutics Inc. - Key offerings
Exhibits119: Aclaris Therapeutics Inc. - Segment focus
Exhibits120: Bausch Health Companies Inc. - Overview
Exhibits121: Bausch Health Companies Inc. - Business segments
Exhibits122: Bausch Health Companies Inc. - Key news
Exhibits123: Bausch Health Companies Inc. - Key offerings
Exhibits124: Bausch Health Companies Inc. - Segment focus
Exhibits125: Croda International Plc - Overview
Exhibits126: Croda International Plc - Business segments
Exhibits127: Croda International Plc - Key news
Exhibits128: Croda International Plc - Key offerings
Exhibits129: Croda International Plc - Segment focus
Exhibits130: Galderma SA - Overview
Exhibits131: Galderma SA - Product / Service
Exhibits132: Galderma SA - Key news
Exhibits133: Galderma SA - Key offerings
Exhibits134: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits135: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits136: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits137: Journey Medical Corp. - Overview
Exhibits138: Journey Medical Corp. - Product / Service
Exhibits139: Journey Medical Corp. - Key offerings
Exhibits140: LEO Pharma AS - Overview
Exhibits141: LEO Pharma AS - Business segments
Exhibits142: LEO Pharma AS - Key offerings
Exhibits143: LEO Pharma AS - Segment focus
Exhibits144: Lupin Ltd. - Overview
Exhibits145: Lupin Ltd. - Product / Service
Exhibits146: Lupin Ltd. - Key news
Exhibits147: Lupin Ltd. - Key offerings
Exhibits148: Maruho Co. Ltd. - Overview
Exhibits149: Maruho Co. Ltd. - Product / Service
Exhibits150: Maruho Co. Ltd. - Key offerings
Exhibits151: Mayne Pharma Group Ltd. - Overview
Exhibits152: Mayne Pharma Group Ltd. - Business segments
Exhibits153: Mayne Pharma Group Ltd. - Key news
Exhibits154: Mayne Pharma Group Ltd. - Key offerings
Exhibits155: Mayne Pharma Group Ltd. - Segment focus
Exhibits156: Pfizer Inc. - Overview
Exhibits157: Pfizer Inc. - Product / Service
Exhibits158: Pfizer Inc. - Key news
Exhibits159: Pfizer Inc. - Key offerings
Exhibits160: Sol-Gel Technologies Ltd. - Overview
Exhibits161: Sol-Gel Technologies Ltd. - Product / Service
Exhibits162: Sol-Gel Technologies Ltd. - Key offerings
Exhibits163: Taro Pharmaceutical Industries Ltd. - Overview
Exhibits164: Taro Pharmaceutical Industries Ltd. - Product / Service
Exhibits165: Taro Pharmaceutical Industries Ltd. - Key offerings
Exhibits166: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits167: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits168: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits169: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits170: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits171: Zydus Lifesciences Ltd. - Overview
Exhibits172: Zydus Lifesciences Ltd. - Business segments
Exhibits173: Zydus Lifesciences Ltd. - Key offerings
Exhibits174: Zydus Lifesciences Ltd. - Segment focus
Exhibits175: Inclusions checklist
Exhibits176: Exclusions checklist
Exhibits177: Currency conversion rates for US$
Exhibits178: Research methodology
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Information sources
Exhibits181: List of abbreviations